1.
Prevention of Diabetes in Women with a History of Gestational Diabetes: Effects of Metformin and Lifestyle Interventions
by Ratner, Robert E
The journal of clinical endocrinology and metabolism, 2008-12, Vol.93 (12), p.4774-4779
2.
Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in Type 2 diabetes inadequately controlled on a...
by Rosenstock, Julio
Journal of diabetes and its complications, 2014, Vol.28 (3), p.386-392
3.
Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW
by Tripathy, Devjit
The journal of clinical endocrinology and metabolism, 2016-05, Vol.101 (5), p.2056-2062
4.
A Novel Insulin Resistance Index to Monitor Changes in Insulin Sensitivity and Glucose Tolerance: the ACT NOW Study
by Tripathy, Devjit
The journal of clinical endocrinology and metabolism, 2015-05, Vol.100 (5), p.1855-1862
5.
Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy
by Bolton, W. Kline
American journal of nephrology, 2004-02, Vol.24 (1), p.32-40
6.
Differential Effects of Oral Hypoglycemic Agents on Glucose Control and Cardiovascular Risk
by Uwaifo, Gabriel I., MD
The American journal of cardiology, 2007, Vol.99 (4), p.51-67
7.
Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: A randomized, double-blind, two-arm, parallel-group, placebo-controlled...
by Schwartz, Sherwyn L., MD
Clinical therapeutics, 2008, Vol.30 (5), p.858-867
8.
Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): Study design and baseline characteristi...
by Ratner, Robert E., MD
The American heart journal, 2008, Vol.156 (6), p.1074-1079
9.
Evaluation of in-stent restenosis in the APPROACH trial (assessment on the prevention of progression by Rosiglitazone on atherosclerosis in diabetes patients with cardiovascular hi...
by Garcia Garcia, Hector
The International Journal of Cardiovascular Imaging, 2012, Vol.28 (3), p.455-465
10.
Relationship of glycemia control to lipid and blood pressure lowering and atherosclerosis: the SANDS experience
by Mete, Mihriye
Journal of diabetes and its complications, 2011, Vol.25 (6), p.362-367
11.
Examination of lower targets for low-density lipoprotein cholesterol and blood pressure in diabetes—the Stop Atherosclerosis in Native Diabetics Study (SANDS)
by Russell, Marie
The American heart journal, 2006, Vol.152 (5), p.867-875
12.
Sitagliptin: an oral agent for glucose control
by Bardsley, Joan K
Expert review of endocrinology & metabolism, 2008-11-01, Vol.3 (6), p.691-697
13.
Value of peripheral vascular endothelial function in the detection of relative myocardial ischemia in asymptomatic type 2 diabetic patients who underwent myocardial perfusion imagi...
by Papaioannou, Georgios I
Journal of nuclear cardiology, 2006, Vol.13 (3), p.362-368
14.
Controlling postprandial hyperglycemia
by Ratner, Robert E
The American journal of cardiology, 2001, Vol.88 (6), p.26-31
15.
The Effect of Lifestyle Intervention and Metformin on Preventing or Delaying Diabetes Among Women With and Without Gestational Diabetes: The Diabetes Prevention Program Outcomes St...
by Aroda, V. R
The journal of clinical endocrinology and metabolism, 2015-04, Vol.100 (4), p.1646-1653
16.
Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetes
by Ratner, Robert E
Diabetes technology & therapeutics, 2002, Vol.4 (1), p.51-61
17.
Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics–Brachial Artery Rea...
by Papaioannou, Georgios I
The American journal of cardiology, 2004, Vol.94 (3), p.294-299
18.
Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study
by Perreault, Leigh, MD
The Lancet (British edition), 2012, Vol.379 (9833), p.2243-2251
19.
Combination oral agent and insulin therapy for type 2 diabetes mellitus
by Passaro, M D
Current diabetes reports, 2001-10, Vol.1 (2), p.106-111
20.
Controlling postprandial hyperglycemia: A Symposium: The Postprandial State: Managing Its Atherogenic Potential
by RATNER, Robert E
The American journal of cardiology, 2001, Vol.88 (6A), p.26H-31H
